Abiopharma

(99% Neutral) Codexis, Inc. (CDXS) Announces New Board Appointment

(86% Positive) EyePoint Pharmaceuticals, Inc. (EYPT) Provides Update on anticipated for DEXYCU after December 31

(99% Neutral) Summit Therapeutics Inc. (SMMT) Files Form 8-K

(99% Neutral) EIGER BIOPHARMACEUTICALS, INC. (EIGR) Announces New Board Appointment

(10% Negative) Ultragenyx Pharmaceutical Inc. (RARE) Announces Delay in improvement Trials for multiple domains U Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(99% Neutral) Eagle Pharmaceuticals, Inc. (EGRX) Announces Executive Departure

(99% Neutral) BELLUS Health Inc (the company became a subdivision of the company GSK (NYSE: GSK)) (BLU) Files Form 6-K

(70% Positive) Genmab (GMAB) Announces Clinical Development Update (Form 6-K)

(99% Neutral) Bicycle Therapeutics plc (BCYC) Announces Business Combination

(99% Positive) NRX PHARMACEUTICALS, INC. (NRXP) Provides Update on Company for success